Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y12 antagonists for inhibition of platelet aggregation

被引:25
作者
Caroff, Eva [1 ]
Meyer, Emmanuel [1 ]
Treiber, Alexander [1 ]
Hilpert, Kurt [1 ]
Riederer, Markus A. [1 ]
机构
[1] Actelion Pharmaceut Ltd, Drug Discovery & Preclin Res & Dev, CH-4123 Allschwil, Switzerland
关键词
P2Y(12) receptor; P2Y(12) antagonist; GPCR antagonist; Antiplatelet; Antithrombotic; DIPHOSPHATE RECEPTOR ANTAGONISTS; PRASUGREL ACHIEVES GREATER; ASPIRIN-TREATED PATIENTS; ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA; ARTERY-DISEASE; CLOPIDOGREL; ACTIVATION; MECHANISMS; THERAPIES;
D O I
10.1016/j.bmcl.2014.06.070
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Phenyl-pyrimidine-4-carboxamide analogs were identified as P2Y(12) antagonists. Optimization of the carbon-linked or nitrogen-linked substituent at the 6-position of the pyrimidine ring provided compounds with excellent ex vivo potency in the platelet aggregation assay in human plasma. Compound 23u met the objectives for activity, selectivity and ADMET properties. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4323 / 4331
页数:9
相关论文
共 33 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E., II ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Ettinger, Steven M. ;
Ganiats, Theodore G. ;
Jneid, Hani ;
Philippides, George J. ;
Zidar, James Patrick ;
Jacobs, Alice K. ;
Albert, Nancy ;
Hochman, Judith S. ;
Creager, Mark A. ;
Kushner, Frederick G. ;
Ohman, Erik Magnus ;
Guyton, Robert A. ;
Stevenson, William G. ;
Halperin, Jonathan L. ;
Yancy, Clyde W. .
CIRCULATION, 2011, 123 (18) :E426-E579
[3]   P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries [J].
André, P ;
Delaney, SM ;
LaRocca, T ;
Vincent, D ;
DeGuzman, F ;
Jurek, M ;
Koller, B ;
Phillips, DR ;
Conley, PB .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :398-406
[4]   Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding [J].
Andre, Patrick ;
DeGuzman, Francis ;
Haberstock-Debic, Helena ;
Mills, Scott ;
Pak, Yvonne ;
Inagaki, Mayuko ;
Pandey, Anjali ;
Hollenbach, Stanley ;
Phillips, David R. ;
Conley, Pamela B. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01) :22-30
[5]   Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies [J].
Becker, Richard C. ;
Gurbel, Paul A. .
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (03) :535-544
[6]  
Bryant J.A., 2002, [No title captured], Patent No. [WO 098856, 098856]
[7]  
Bryant J.A., 2004, [No title captured], Patent No. [WO 052366, 052366]
[8]   Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I):: In vitro effects on platelets [J].
Bryant, Judi ;
Post, Joseph M. ;
Alexander, Serene ;
Wang, Yi-Xin ;
Kent, Lorraine ;
Schirm, Sabine ;
Tseng, Jih-Lie ;
Subramanyam, Babu ;
Buckman, Brad ;
Islam, Imadul ;
Yuan, Shendong ;
Sullivan, Mark E. ;
Snider, Mike ;
Morser, John .
THROMBOSIS RESEARCH, 2008, 122 (04) :523-532
[9]  
Caroff E., 2008, [No title captured], Patent No. [WO 050301, 050301]
[10]  
Caroff E., 2006, [No title captured], Patent No. [WO 114774, 114774]